Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study.

Dalon F, Roche N, Belhassen M, Nolin M, Pegliasco H, Deslée G, Housset B, Devillier P, Van Ganse E.

Int J Chron Obstruct Pulmon Dis. 2019 Aug 20;14:1839-1854. doi: 10.2147/COPD.S214061. eCollection 2019.

2.

Assessment of TNF-α inhibitors in airway involvement of relapsing polychondritis: A systematic review.

Biya J, Dury S, Perotin JM, Launois C, Dewolf M, Deslée G, Lebargy F.

Medicine (Baltimore). 2019 Nov;98(44):e17768. doi: 10.1097/MD.0000000000017768.

3.

Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC.

Ancel J, Birembaut P, Dewolf M, Durlach A, Nawrocki-Raby B, Dalstein V, Delepine G, Blacher S, Deslée G, Gilles C, Polette M.

Cancers (Basel). 2019 Sep 22;11(10). pii: E1411. doi: 10.3390/cancers11101411.

4.

Relationship between gender and survival in a real-life cohort of patients with COPD.

Zysman M, Burgel PR, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Surpas P, Deslée G, Perez T, Le Rouzic O, Jebrak G, Chanez P, Paillasseur JL, Caillaud D, Roche N; Initiatives BPCO scientific committee and investigators.

Respir Res. 2019 Aug 22;20(1):191. doi: 10.1186/s12931-019-1154-3.

5.

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe COPD (AIRFLOW): A Multicenter Randomized Controlled Trial.

Slebos DJ, Shah PL, Herth FJ, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Srikanthan K, Duller M, Valipour A; AIRFLOW-2 Trial Study Group.

Am J Respir Crit Care Med. 2019 Aug 12. doi: 10.1164/rccm.201903-0624OC. [Epub ahead of print]

PMID:
31404499
6.

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.

Perez T, Deslée G, Burgel PR, Caillaud D, Le Rouzic O, Zysman M, Escamilla R, Jebrak G, Chanez P, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Paillasseur JL, Roche N; Initiatives BPCO Scientific Committee.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 2;14:1399-1410. doi: 10.2147/COPD.S188412. eCollection 2019.

7.

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD.

Maltais F, Ferguson GT, Feldman GJ, Deslee G, Bourdin A, Fjällbrant H, Siwek-Posłuszna A, Jenkins MA, Martin UJ.

Adv Ther. 2019 Sep;36(9):2434-2449. doi: 10.1007/s12325-019-01015-3. Epub 2019 Jul 2.

PMID:
31267366
8.

Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients.

Valipour A, Shah PL, Pison C, Ninane V, Janssens W, Perez T, Kessler R, Deslee G, Garner J, Abele C, Hartman JE, Slebos DJ; On behalf of the AIRFLOW-1 Study Group.

Respiration. 2019;98(4):329-339. doi: 10.1159/000500463. Epub 2019 Jun 20.

9.

Successful Lung Volume Reduction Surgery after Endobronchial Coils Treatment in a Severe Emphysematous Patient.

Dutau H, Deslée G, Bregeon F, Astoul P, Thomas P.

Respiration. 2019;98(2):174-177. doi: 10.1159/000499682. Epub 2019 May 22.

PMID:
31117089
10.

Prevalence and management of chronic breathlessness in COPD in a tertiary care center.

Carette H, Zysman M, Morelot-Panzini C, Perrin J, Gomez E, Guillaumot A, Burgel PR, Deslee G, Surpas P, Le Rouzic O, Perez T, Chaouat A, Roche N, Chabot F; Initiatives BPCO (bronchopneumopathie chronique obstructive) Scientific Committee and Investigators.

BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5.

11.

Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.

Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth FJF, Shah PL; RENEW Study Group.

Chest. 2019 May;155(5):928-937. doi: 10.1016/j.chest.2019.02.012. Epub 2019 Feb 21.

PMID:
30797746
12.

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency.

Perotin JM, Leroy S, Marquette CH, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Barbe C, Deslee G; REVOLENS Study Group.

Int J Chron Obstruct Pulmon Dis. 2018 Nov 5;13:3645-3649. doi: 10.2147/COPD.S176366. eCollection 2018.

13.

Endobronchial Coils Versus Lung Volume Reduction Surgery or Medical Therapy for Treatment of Advanced Homogenous Emphysema.

Marchetti N, Kaufman T, Chandra D, Herth FJ, Shah PL, Slebos DJ, Dass C, Bicknell S, Blaas SH, Pfeifer M, Stanzell F, Witt C, Deslee G, Gesierich W, Hetzel M, Kessler R, Leroy S, Hetzel J, Sciurba FC, Criner GJ.

Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):87-96. doi: 10.15326/jcopdf.5.2.2017.0134.

14.

Hereditary multiple exostoses of the ribs as an uncommon cause of pneumothorax: A case report.

Dumazet A, Launois C, Dury S, Sailhan F, Alifano M, Dewolf M, Lebargy F, Deslee G, Perotin JM.

Medicine (Baltimore). 2018 Aug;97(35):e11894. doi: 10.1097/MD.0000000000011894.

15.

Adoption Patterns of Bronchoscopic Lung Volume Reduction Procedures in Germany and Predicted Procedure Volumes for Other European Countries.

Pietzsch JB, Busca R, Rott C, Geisler BP, Weber SA, Slebos DJ, Deslee G, Herth FJF.

Respiration. 2019;97(1):34-41. doi: 10.1159/000491677. Epub 2018 Aug 17.

PMID:
30121662
16.

Long-term safety of bilateral targeted lung denervation in patients with COPD.

Valipour A, Asadi S, Pison C, Jondot M, Kessler R, Benneddif K, Deslee G, Verdier M, Slebos DJ, Mayse M.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 16;13:2163-2172. doi: 10.2147/COPD.S158748. eCollection 2018.

17.

Endobronchial Lung Volume Reduction in Severe Emphysema. Time to Translate Randomized Controlled Trial Results into Routine Clinical Practice?

Deslee G.

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1110-1112. doi: 10.1164/rccm.201805-0983ED. No abstract available.

PMID:
29939769
18.

Managing patients with chronic cough: challenges and solutions.

Perotin JM, Launois C, Dewolf M, Dumazet A, Dury S, Lebargy F, Dormoy V, Deslee G.

Ther Clin Risk Manag. 2018 Jun 6;14:1041-1051. doi: 10.2147/TCRM.S136036. eCollection 2018.

19.

Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).

Bulsei J, Leroy S, Perotin JM, Mal H, Marquette CH, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dukic S, Barbe C, Bonnaire M, Deslee G, Durand-Zaleski I; REVOLENS study group.

Respir Res. 2018 May 9;19(1):84. doi: 10.1186/s12931-018-0796-x.

20.

Alteration of primary cilia in COPD.

Perotin JM, Coraux C, Lagonotte E, Birembaut P, Delepine G, Polette M, Deslée G, Dormoy V.

Eur Respir J. 2018 Jul 11;52(1). pii: 1800122. doi: 10.1183/13993003.00122-2018. Print 2018 Jul. No abstract available.

PMID:
29678947
21.

Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysema.

Evans R, Brutsche M, Busca R, Deslee G, de Soyza A, Fellrath JM, Franzen D, Hartman J, Mealing S, Morton T, Munavvar M, Sculpher M, Shah P, Slebos DJ, Durand-Zaleski I.

Curr Med Res Opin. 2018 Nov;34(11):1927-1932. doi: 10.1080/03007995.2018.1462784. Epub 2018 May 8.

PMID:
29625529
22.

Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.

Deslée G, Leroy S, Perotin JM, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dury S, Benzaquen J, Bonnaire M, Dukic S, Barbe C, Marquette CH; , on behalf of the REVOLENS Study Group13; REVOLENS Study Group.

Eur Respir J. 2017 Dec 21;50(6). pii: 1701740. doi: 10.1183/13993003.01740-2017. Print 2017 Dec. No abstract available.

23.

Improvement of dyspnea after bariatric surgery is associated with increased Expiratory Reserve Volume: A prospective follow-up study of 45 patients.

Boissière L, Perotin-Collard JM, Bertin E, Gaubil I, Diaz Cives A, Barbe C, Dury S, Nardi J, Lebargy F, Deslée G, Launois C.

PLoS One. 2017 Sep 20;12(9):e0185058. doi: 10.1371/journal.pone.0185058. eCollection 2017.

24.

Changes in dynamic lung mechanics after lung volume reduction coil treatment of severe emphysema.

Makris D, Leroy S, Pradelli J, Benzaquen J, Guenard H, Perotin JM, Zakynthinos S, Zakynthinos E, Deslee G, Marquette CH.

Thorax. 2018 Jun;73(6):584-586. doi: 10.1136/thoraxjnl-2017-210118. Epub 2017 Sep 11.

PMID:
28893857
25.

Bronchiectasis Complicating Lung Volume Reduction Coil Treatment.

Debray MP, Marceau A, Dombret MC, Bunel V, Leroy S, Deslée G, Mal H.

Chest. 2017 Sep;152(3):e57-e60. doi: 10.1016/j.chest.2017.04.189.

PMID:
28889896
26.

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.

Zysman M, Deslee G, Caillaud D, Chanez P, Escamilla R, Court-Fortune I, Nesme-Meyer P, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N, Burgel PR.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 20;12:1819-1824. doi: 10.2147/COPD.S129787. eCollection 2017.

27.

Lung volume reduction for emphysema - Authors' reply.

van Geffen WH, Herth FJ, Deslee G, Slebos DJ, Shah PL.

Lancet Respir Med. 2017 Jul;5(7):e24. doi: 10.1016/S2213-2600(17)30232-1. No abstract available.

PMID:
28664863
28.

Nuclear protein in testis carcinoma of the mediastinum: a case report.

Boleto G, Perotin JM, Launois C, Uro-Coste E, Birembaut P, Dury S, Vallerand H, Lebargy F, Deslée G, Vella-Boucaud J.

J Med Case Rep. 2017 Jun 9;11(1):152. doi: 10.1186/s13256-017-1328-x.

29.

[Changing patterns of medication prescription for COPD patients in France. Impact of long-acting muscarinic antagonists' availability].

Jébrak G, Burgel PR, Caillaud D, Deslée G, Brinchault G, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Pinet C, Perez T, Paillasseur JL, Roche N; pour le groupe Initiatives BPCO.

Rev Mal Respir. 2017 May;34(5):535-543. doi: 10.1016/j.rmr.2017.02.006. Epub 2017 May 31. French.

PMID:
28578989
30.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N.

Rev Mal Respir. 2017 Apr;34(4):282-322. doi: 10.1016/j.rmr.2017.03.034. Epub 2017 May 25.

PMID:
28552256
31.

[Which inhaled pharmacological treatments for COPD acute exacerbations in hospital?]

Perotin JM, Piquet J, Deslee G.

Rev Mal Respir. 2017 Apr;34(4):413-415. doi: 10.1016/j.rmr.2017.03.027. Epub 2017 May 10. French. No abstract available.

PMID:
28502364
32.

[Which inhaled pharmacological treatment during acute COPD exacerbation in community-based practice?]

Perotin JM, Deslee G.

Rev Mal Respir. 2017 Apr;34(4):395-396. doi: 10.1016/j.rmr.2017.03.018. Epub 2017 May 8. French. No abstract available.

PMID:
28495294
33.

[Systemic lupus erythematosus presenting as severe alveolar hypoventilation and the shrinking lung syndrome].

Ammar Y, Launois C, Perotin JM, Dury S, Servettaz A, Perdu D, Vallerand H, Nardi J, Boulagnon-Rombi C, Pluot M, Lebargy F, Deslee G.

Rev Mal Respir. 2017 May;34(5):571-575. doi: 10.1016/j.rmr.2016.10.875. Epub 2017 Feb 8. French.

PMID:
28189434
34.

Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.

Burgel PR, Le Gros V, Decuypère L, Bourdeix I, Perez T, Deslée G.

BMC Pulm Med. 2017 Jan 31;17(1):25. doi: 10.1186/s12890-017-0372-z.

35.

Micronodular pattern of organizing pneumonia: Case report and systematic literature review.

Lebargy F, Picard D, Hagenburg J, Toubas O, Perotin JM, Sandu S, Deslee G, Dury S.

Medicine (Baltimore). 2017 Jan;96(3):e5788. doi: 10.1097/MD.0000000000005788. Review.

36.

Successful Late Removal of Endobronchial Coils.

Dutau H, Bourru D, Guinde J, Laroumagne S, Deslée G, Astoul P.

Chest. 2016 Dec;150(6):e143-e145. doi: 10.1016/j.chest.2016.03.026.

PMID:
27938769
37.

[Which treatments for the hyperventilation syndrome in adults?]

Rapin A, Deslee G, Percebois-Macadre L, Jonvel AC, Demangeon S, Boyer FC.

Rev Mal Respir. 2017 Feb;34(2):93-101. doi: 10.1016/j.rmr.2016.07.005. Epub 2016 Oct 12. Review. French.

PMID:
27743828
38.

Impact of current cough on health-related quality of life in patients with COPD.

Deslee G, Burgel PR, Escamilla R, Chanez P, Court-Fortune I, Nesme-Meyer P, Brinchault-Rabin G, Perez T, Jebrak G, Caillaud D, Paillasseur JL, Roche N.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 13;11:2091-2097. eCollection 2016.

39.

Lung volume reduction for emphysema.

Shah PL, Herth FJ, van Geffen WH, Deslee G, Slebos DJ.

Lancet Respir Med. 2017 Feb;5(2):147-156. doi: 10.1016/S2213-2600(16)30221-1. Epub 2016 Sep 29. Review. Erratum in: Lancet Respir Med. 2016 Nov;4(11):e55.

PMID:
27693408
40.

Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?

Caillaud D, Chanez P, Escamilla R, Burgel PR, Court-Fortune I, Nesme-Meyer P, Deslee G, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N; Initiatives BPCO scientific committee and investigators.

Allergy. 2017 Jan;72(1):137-145. doi: 10.1111/all.13004. Epub 2016 Sep 27.

PMID:
27501862
41.

[Multiple pulmonary opacities revealing toxocariasis].

Jorge D, Strady C, Guy B, Deslée G, Lebargy F, Dury S.

Rev Pneumol Clin. 2016 Aug;72(4):273-6. doi: 10.1016/j.pneumo.2016.03.004. Epub 2016 Jun 28. French.

PMID:
27368139
42.

Lung Volume Reduction Coils for Severe Emphysema--Reply.

Deslée G, Marquette CH; REVOLENS Study Group.

JAMA. 2016 Jun 21;315(23):2621-2. doi: 10.1001/jama.2016.3486. No abstract available.

PMID:
27327811
43.

Obstructive Fibrinous Tracheal Pseudomembrane.

Ammar Y, Vella-Boucaud J, Launois C, Vallerand H, Dury S, Lebargy F, Deslee G, Perotin JM.

Anesth Analg. 2017 Jul;125(1):172-175. doi: 10.1213/ANE.0000000000001408.

PMID:
27258072
44.

Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.

Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, Deslée G, Tillis WP, Delage A, Marquette CH, Krishna G, Kalhan R, Ferguson JS, Jantz M, Maldonado F, McKenna R, Majid A, Rai N, Gay S, Dransfield MT, Angel L, Maxfield R, Herth FJ, Wahidi MM, Mehta A, Slebos DJ; RENEW Study Research Group.

JAMA. 2016 May 24-31;315(20):2178-89. doi: 10.1001/jama.2016.6261.

45.

Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de Pneumologie de Langue Française (SPLF) (Full length text).

Raherison C, Bourdin A, Bonniaud P, Deslée G, Garcia G, Leroyer C, Taillé C, De Blic J, Dubus JC, Tillié-Leblond I, Chanez P.

Rev Mal Respir. 2016 Apr;33(4):279-325. doi: 10.1016/j.rmr.2016.03.002. Epub 2016 Apr 14. No abstract available.

PMID:
27147308
46.

Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de pneumologie de langue française (SPLF) (summary).

Raherison C, Bourdin A, Bonniaud P, Deslée G, Garcia G, Leroyer C, Taillé C, De Blic J, Dubus JC, Tillié-Leblond I, Chanez P.

Rev Mal Respir. 2016 Apr;33(4):271-8. doi: 10.1016/j.rmr.2016.03.001. Epub 2016 Apr 23. No abstract available.

PMID:
27117926
47.

Respiratory Conditions Associated with Tracheobronchomegaly (Mounier-Kuhn Syndrome): A Study of Seventeen Cases.

Schmitt P, Dalar L, Jouneau S, Toublanc B, Camuset J, Chatte G, Cellerin L, Dutau H, Sanchez S, Sauvage M, Vergnon JM, Dury S, Deslée G, Lebargy F; Groupe d''Endoscopie de Langue Française (GELF).

Respiration. 2016;91(4):281-7. doi: 10.1159/000445029. Epub 2016 Mar 25.

48.

Tracheobronchial Involvement of Rosai-Dorfman Disease: Case Report and Review of the Literature.

Boissière L, Patey M, Toubas O, Vella-Boucaud J, Perotin-Collard JM, Deslée G, Lebargy F, Dury S.

Medicine (Baltimore). 2016 Feb;95(7):e2821. doi: 10.1097/MD.0000000000002821. Review.

49.

Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.

Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group.

JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821.

PMID:
26757466
50.

Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors.

Brasseur M, Heurgué-Berlot A, Barbe C, Brami C, Rey JB, Vella-Boucaud J, Dabouz F, Deslée G, Grange F, Volet J, Bouché O.

BMC Cancer. 2015 Dec 23;15:999. doi: 10.1186/s12885-015-2033-z.

Supplemental Content

Loading ...
Support Center